Fingerprint
Dive into the research topics of 'Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer
J. D. Hurt, D. L. Richardson, L. G. Seamon, J. F. Fowler, L. J. Copeland, D. E. Cohn, E. Eisenhauer, R. Salani, D. M. O'Malley
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations